Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Number of holders
-
249
-
Total 13F shares, excl. options
-
50,672,122
-
Shares change
-
+1,668,800
-
Total reported value, excl. options
-
$3,375,443,272
-
Value change
-
-$52,557,812
-
Put/Call ratio
-
99.72%
-
Number of buys
-
149
-
Number of sells
-
-158
-
Price
-
$66.64
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2021
348 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q2 2021.
HAEMONETICS CORP - Common Stock (HAE) has 249 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,672,122 shares
.
Largest 10 shareholders include BlackRock Inc. (5,979,303 shares), VANGUARD GROUP INC (4,887,681 shares), Neuberger Berman Group LLC (3,734,941 shares), WELLINGTON MANAGEMENT GROUP LLP (3,691,189 shares), Capital Research Global Investors (2,679,336 shares), STATE STREET CORP (1,674,954 shares), FRANKLIN RESOURCES INC (1,341,489 shares), Fisher Asset Management, LLC (1,098,733 shares), LONDON CO OF VIRGINIA (1,052,983 shares), and LGT CAPITAL PARTNERS LTD. (953,425 shares).
This table shows the top 249 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.